Metabolite Profiling of Guipi Pill Using UHPLC‐Q‐Orbitrap‐HRMS and Determination of the Pharmacokinetics of its Major Prototype Components
Journal of Separation Science · 2025-09 · 48 (9)
DOI: 10.1002/jssc.70257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, online erschienen am 03.09.2025. Verfasst von Huafang Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Science Research Fund Project of Liaoning Provincial Department of Education.
Abstract (Originalsprache)
Guipi Pill (GPP), a classic traditional formula used to treat anxiety disorders, demonstrates significant pharmacological activity. However, research on its pharmacodynamic material basis remains limited. UHPLC‐Q‐Orbitrap‐HRMS was used to systematically analyze the metabolites of GPP in the blood, urine, bile, and feces of rats after oral administration and elucidate its in vivo metabolic processes. The pharmacokinetic characteristics of the major prototype components were determined using UHPLC‐MS/MS. A total of 106 compounds (48 prototype components and 58 metabolites) were identified in GPP, which included the following six structural classes: phenylpropanoids, flavonoids and their glycosides, terpenoids and their glycosides, volatile oils, organic acids, and acetylenic glycosides. Nine of the metabolites were presumed to be novel compounds, which were previously unreported. Metabolic pathways involved Phase I reactions (hydrolysis, methylation, oxidation) and Phase II reactions (glucuronidation or sulfation of Phase I metabolites). Pharmacokinetic analysis revealed flavonoid glycosides (e.g., liquiritin) to exhibit a short time to attain maximum concentration ( T max ), short elimination half‐life ( t 1/2 ), and short mean residence time (MRT), consistent with their structural features, whereas terpenoids (e.g., costunolide, atractylenolide I, dehydrocostus lactone, glycyrrhetinic acid) showed slow absorption, slow elimination, and a long MRT. The volatile oil, ligustilide, demonstrated rapid absorption and a long t 1/2 . This study systematically delineates the metabolic characteristics and pharmacokinetic profiles of the major constituents of GPP in rats, providing a scientific basis for the further elucidation of its pharmacodynamic material basis and mechanisms of metabolic regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.
- Yunnan Center for Animal Disease Control and Prevention, Kunming, China.
- School of Pharmacy, Shenyang Medical College, Shenyang, China.
Förderung
- Science Research Fund Project of Liaoning Provincial Department of Education
Zitieren
APA
Bai, H., Wang, H., Yuan, N., Zhang, H., Sun, Q., Wang, M., & Gao, J. (2025). Metabolite Profiling of Guipi Pill Using UHPLC‐Q‐Orbitrap‐HRMS and Determination of the Pharmacokinetics of its Major Prototype Components. Journal of Separation Science, 48(9). https://doi.org/10.1002/jssc.70257
Vancouver
Bai H, Wang H, Yuan N, Zhang H, Sun Q, Wang M, et al. Metabolite Profiling of Guipi Pill Using UHPLC‐Q‐Orbitrap‐HRMS and Determination of the Pharmacokinetics of its Major Prototype Components. Journal of Separation Science. 2025;48(9). doi:10.1002/jssc.70257
BibTeX
@article{Bai2025,
author = {Bai, Huafang and Wang, Hongjin and Yuan, Nannan and Zhang, Hui and Sun, Qi and Wang, Mengru and Gao, Jinwei},
title = {Metabolite Profiling of Guipi Pill Using UHPLC‐Q‐Orbitrap‐HRMS and Determination of the Pharmacokinetics of its Major Prototype Components},
journal = {Journal of Separation Science},
year = {2025},
volume = {48},
number = {9},
doi = {10.1002/jssc.70257}
}
EUVIMED